Skip to main content
Industry News
Physicians call for release of remdesivir trial data
5/22/2020

US physicians and others in the scientific sector are calling for the release of the complete trial findings that convinced the FDA to grant emergency use authorization to Gilead Sciences' antiviral drug remdesivir to treat COVID-19. "We want to direct the drug to those most likely to benefit and least likely to be harmed," Dr. Helen Boucher, chief of infectious diseases at Tufts Medical Center, said.

Full Story: